manitoba delegation at bio 2011 · 2018. 7. 31. · visit us at the manitoba-canada bio pavilion,...
TRANSCRIPT
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727!
Manitoba Delegation at BIO 2011
• Agriculture and Agri-Food Canada (AAFC) • ANIM - Manitoba's Bilingual Trade Agency • Apotex Fermentation Inc. (AFI) • Cangene Corporation • Composites Innovation Centre Manitoba Inc. (CIC) • Genesys Venture Inc. (GVI) • Genome Prairie • GVI Clinical Development Solutions Inc. • Industrial Technology Centre (ITC) • Life Science Association of Manitoba (LSAM) • Manitoba Agri-Health Research Network Inc. (MAHRN) • Medicure Inc. • Prairie Fire Growth Ventures Inc. • St. Boniface General Hospital Research Centre (SBRC) • Sphaera Technologies Inc. • University of Manitoba – Technology Transfer Office
(TTO)
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name:
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727!
Company Name: Agriculture and Agri-Food Canada (AAFC) Type of Organization: Government Contact Information: BIO Contact: Nathalie Leroux – Senior Marketing and Trade Officer [email protected] Mailing Address: 402-303 Main Street Winnipeg, Manitoba R3C 3G7 Canada Telephone: 204-984-5345 Fax: 204-983-4583 Website: http://www.agr.gc.ca Company Overview / Nature of Major Business Activities: Agriculture and Agri-Food Canada (AAFC) aims to position Canada as a global leader in agricultural productivity and trade. Our Agri-Food Trade Service (ATS) is linked to a network of regional offices, industry specialists and international trade commissioners to help Canadian businesses in the agriculture, food and agri-products sectors seize opportunities at home and abroad. By contacting our Manitoba Regional Office, your business can access multiple federal and provincial services through a single point of entry.
Current Company Focus: AAFC can assist you with:
• domestic and foreign business connections Business Development:
• international market access • industry preparedness through workshops and seminars • innovation and competitiveness • international trade shows
• analysis of key export markets Market and Industry Intelligence:
• consumer trends • domestic and foreign policies and regulations
• Country-specific information at:
www.ats.agr.gc.ca • Subscribe to our bi-monthly Manitoba ATS Bulletin by e-mailing:
• Growing Forward: Industry Programs:
www.agr.gc.ca/growingforward • Agri-Opportunities: www.agr.gc.ca/agri-opportunities • AgriMarketing: www.agr.gc.ca/agrimarketing • Agri-Processing Initiative: www.agr.gc.ca/api RegionalNorth America in General
Market Segments of Interest:
Central America in General South America in General Europe in General Asia in General Africa in General Oceania in General IndustryLife Sciences - Agricultural biotech and bioproducts Life Sciences - Functional foods and nutraceuticals Life Sciences - Industrial biotech (composites/chemicals) Life Sciences - Clean energy / environmental technologies Life Sciences - Aquaculture Agribusiness - food processing Agribusiness - manufacturing & technology Clean energy and environmental industries
Market Segments of Interest:
Goals for BIO: • Promote Canada’s capabilities in agriculture, agricultural biotechnology, bioproducts,
biofuels, and functional foods to the United States and abroad. • Assist Canadian bioproduct and ag biotechnology organizations in expanding new markets
and developing research collaborations.
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: ANIM - Manitoba's Bilingual Trade Agency Type of Organization: Not-for-profit organization Contact Information: BIO Contact: Sarah Zaharia, Business Development Consultant
[email protected] Mailing Address: 3rd Floor 219, boulevard Provencher Winnipeg, Manitoba R2H 0G4 Canada Telephone: 204-479-2356 Fax: 204-254-4162 Website: www.animcanada.com Company Overview / Nature of Major Business Activities: If you are a business seeking entry into Canadian and North American markets, Manitoba is the place to start. Thanks to its strategic location at the centre of North America, Manitoba boasts not only a strong, recession resistant economy, but also excellent financial and trade connections throughout the continent. It also serves as a major transportation hub, affording businesses excellent road, freight and air connections to all points of North America, especially along North America’s North-South trade corridor. Finally, thanks to it being home to a large francophone population, as well as strong immigrant populations from around the world, it also possesses one of the most multilingual workforces in Canada.
All of these assets add up to significant advantages for international businesses seeking an entry point into the North American market. Current Company Focus ANIM, in collaboration with its trade partners, assists businesses establish themselves in North America by using Manitoba as their gateway. To this end we provide a number of consulting and development services, tailored to the needs of the client to help them expedite their business development goals through Manitoba. Regional Market Segments of Interest: North America in General Central America in General South America in General Europe in General – including Belgium, France, Monaco and Switzerland Middle East in General Industry Market Segments of Interest: Life Sciences - Agricultural biotech and bioproducts Life Sciences - Functional foods and nutraceuticals Life Sciences - Industrial biotech (composites/chemicals) Life Sciences - Clean energy / environmental technologies Life Sciences - Medical devices / diagnostics Life Sciences - Aquaculture Aerospace Mining, minerals and petroleum Agribusiness - food processing Agribusiness - manufacturing & technology Electricity, energy and natural gas Clean energy and environmental industries Transportation equipment and manufacturing Transportation and logistics Building products and construction Information and communications technology Digital media, new media, film and sound Customer service Safety and security industry
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: Apotex Fermentation Inc. (AFI) Type of Organization: Company Contact Information: BIO Contact: Dr. Sudha Nair – Director, Global Business Development [email protected] Mailing Address: 50 Scurfield Boulevard Winnipeg, Manitoba R3Y 1G4 Canada Telephone: 204-989-6830 Website: www.apoferm.com Company Overview / Nature of Major Business Activities: Contract Manufacturer for Apotex Pharmachem Inc. (API) Recent Accomplishments / Company Highlights: Experienced team in microbial fermentation. Expertise in strain improvement, media optimization and scale-up to production level. A cGMP compliant, FDA audited facility that has successfully completed various projects for clients in Europe, Canada and the U.S.
Regional Market Segments of Interest: North America in General – Canada, United States of America (including: California, Massachusetts, New Jersey, New York and North Carolina) Europe in General – France, Germany, Switzerland, United Kingdom (and other European biotech hubs) Japan Industry Market Segments of Interest: Life Sciences - Functional foods and nutraceuticals Life Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Goals for BIO: • To increase awareness of AFI in the contract manufacturing market (generate leads) • To identify possible strategic alliance partners
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: Cangene Corporation Type of Organization: Company Contact Information: BIO Contacts: Ashley Wozniak – Director, Business Development [email protected] Mailing Address: 155 Innovation Drive Winnipeg, Manitoba R3T 5Y3 Canada Telephone: 204-275-4200 Website: www.cangene.com Company Overview / Nature of Major Business Activities: Cangene, established in 1984, is a profitable and fully integrated developer and manufacturer of antibody-based therapeutics, with a primary focus on sales in North America. Most of Cangene's products are hyperimmunes-purified antibody products that are specific for targets such as hepatitis B, Botulism and Anthrax. In addition, Cangene is developing monoclonal antibodies and an innovative peptide therapeutic that may be effective in combating certain antibiotic-resistant infections. Current Company Focus: Cangene is interested in acquiring rights to late-stage products for the North American market and is especially interested in niche, hospital-based products which would be supported by a sales group of 30 hospital specialists.
Recent Accomplishments / Company Highlights: • HepaGam B approved by Health Canada for a second indication and in Israel; • Opened new and expanded Winnipeg plasma centre in the Smart Park at the University of
Manitoba; and • Signed new supply agreements with non-North American countries for the supply of BAT
and VIG biodefense products. RegionalNorth America in General – Canada, United States of America
Market Segments of Interest:
IndustryLife Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery
Market Segments of Interest:
Employment Opportunities: Visit: www.cangene.com to search job postings Goals for BIO: Cangene is interested in acquiring the rights to commercial and late stage products for the North American market—and is especially interested in niche hospital-based products. Cangene has a fully integrated commercial infrastructure with warehousing and distribution and is contracted with the major group purchasing organizations (GPOs), wholesalers, distributors and managed care organizations.
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name:
Composites Innovation Centre Manitoba Inc. (CIC)
Type of Organization: Not-for-profit Corporation Contact Information: BIO Contact: Simon Potter [email protected] Mailing Address: 300 - 78 Innovation Drive
Winnipeg, Manitoba R3T 6C2 Canada
Telephone: (204) 262-3400 ext. 209 Fax: (204) 262-3409 Website: www.compositesinnovation.ca Company Overview / Nature of Major Business Activities: The Composites Innovation Centre Manitoba Inc. (CIC) is a not-for-profit corporation that is jointly sponsored by private industry and government. Its mandate is to support and stimulate economic growth through innovative research, development and application of composite materials and technologies for manufacturing industries. This is achieved by working directly with industry, on industry sponsored projects that result in a measurable economic benefit to the project participants and the community. Projects are performed in a collaborative partnership with industry, government agencies, and educational establishments.
Recent Accomplishments / Company Highlights: The CIC provides project management, engineering consulting, process development and testing services to support industry in developing and commercializing composite materials, products and processes.
Many companies have projects they are unable to pursue successfully due to a lack of resources. These resource gaps may be in technical areas, project management, education, funding, or even the absence of a project partner. The CIC has an engineering staff to assist companies by providing proposal preparation, project management and technical and business consulting services. In many cases the CIC has the ability to contribute towards project costs or find alternative funding sources.
The CIC approaches project planning in a strategic manner to optimize the participants’ efforts in preparing and approving project plans. Nondisclosure and intellectual property agreements are incorporated early in the project planning phase to protect even the most discreet projects.
The CIC’s key competence is in its ability to support the planning and implementation of industry sponsored projects by:
• Assembling the most suitable partners
• Facilitating preparation of the work statement/plan
• Negotiating roles and responsibilities
• Developing a suitable funding model that combines industry and
• Government contributions
• Negotiating agreements on intellectual property
• Managing projects and
• Keeping abreast of the latest developments in composite manufacturing
• Technologies and materials
Regional Market Segments of Interest: To support its activities, the CIC is funded by and/or has affiliations with several regional government, research and educational establishments including: Western Economic Diversification Canada, the Province of Manitoba, Destination Winnipeg, National Research Council of Canada, the University of Manitoba, and Red River College.
Industry Market Segments of Interest: The CIC is driven by industry requirements focusing on key sectors: aerospace, biomaterials, ground transportation, and civil infrastructure. Core technologies such as liquid resin molding and automation, and the business sectors that they support, are based on levels of interest and the technology gaps/needs of industry. Capabilities developed around the core technologies assist industry in keeping pace with competitors as well as advancing technologies to provide for a competitive advantage.
Goals for BIO: 1. To showcase Manitoba’s capability in value-added biomaterials production and Winnipeg’s
growing reputation as the “Composites Capital of Canada”.
2. To seek partners to support the development of a supply chain for biomaterials processing in Manitoba.
3. To seek partner industry to assist in the commercialization of advanced biomaterials in the CIC’s target sectors.
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name:
Genesys Venture Inc. (GVI) Type of Organization: Company Contact Information: BIO Contact: Dr. Albert Friesen – President [email protected] Jason Leibert – Business Development Manager [email protected] Mailing Address: 4-1250 Waverley Street Winnipeg, Manitoba R3T 6C6 Canada Telephone: 204-487-2328 Fax: 204-453-1370 Website: www.genesysventure.com Company Overview / Nature of Major Business Activities: Successful commercialization of health technology requires quality innovation plus experienced management, market and technical expertise, and access to sufficient capital. Genesys Venture Inc. (GVI) provides the expertise, experience and energy required to start-up and manage emerging health and biotechnology ventures. Founded by renowned bio-entrepreneur Dr. Albert D. Friesen, the GVI team has extensive experience to offer its clients. The GVI concept is an enhanced technology-based business incubator, developing a partnership with the technology holders and/or investors to help ensure successful startup and provide strategic direction to research and business activities
GVI has experience in providing the following services through active participation typical of an enhanced incubation model: • start-up; • early-mid stage capitalization; • technology development; • intellectual property management; • business development; • support services; and • consultation.
Where necessary, additional expertise is drawn from GVI's vast personal network. In addition to incubation, GVI provides consulting services to industry and public organizations on issues related to health technology and bio-industry development. Industry Market Segments of Interest: Life Sciences - Agricultural biotech and bioproducts Life Sciences - Functional foods and nutraceuticals Life Sciences - Clean energy / environmental technologies Life Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Life Sciences - Medical devices / diagnostics
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: Genome Prairie Type of Organization: Not-for-profit organization Contact Information: BIO Contact: Carol Reynolds – Director
Communications and Government Relations [email protected] Mailing Address: #101 - 111 Research Drive
Saskatoon, SK S7N 3R2 Canada Telephone: (306) 668-3574 Fax: (306) 668-3580 Website: www.genomeprairie.ca Company Overview / Nature of Major Business Activities: Genome Prairie manages and supports innovative, large-scale genomics research projects in Manitoba and Saskatchewan. Industry sectors such as agriculture, health, mining and energy are benefitting from the organization’s research and commercialization initiatives. With its partners, Genome Prairie has supported more than $197 million of research activity in plant, animal and human genomics, bioinformatics, instrumentation development and bioethics since its establishment in 2000. Through network establishment and regional priority consultations, Genome Prairie works collaboratively with all levels of government, universities and industry as well as Genome Canada, a not-for-profit organization implementing a national strategy in genomics and related bioscience research to benefit all Canadians.
Genome Prairie has three key roles: 1. Manage projects and facilitate regional participation and co-funding for Genome Canada
and other genomics research projects in Saskatchewan and Manitoba. 2. Provide regional leadership and support for collaborative efforts for genomic and bioscience
research and knowledge transfer for the provinces of Manitoba and Saskatchewan. 3. Promote awareness of recent advancements and societal impacts of genomics and
bioscience research to government, industry, public and other stakeholders. RegionalAll of Canada
Market Segments of Interest:
IndustryAgriculture, Health, Environment, Science Education Promotion
Market Segments of Interest:
Goals for BIO: 1. Increase GP exposure, build GP brand regionally, nationally, internationally. 2. Meet potential research, industry collaborators.
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name:
GVI Clinical Development Solutions Inc. Type of Organization: Company Contact Information: BIO Contacts: Jan-Ake Westin – President [email protected] Jason Leibert - Business Development Manager [email protected] Mailing Address: 4-1250 Waverley Street Winnipeg, Manitoba R3T 6C6 Canada Telephone: 705-291-0176 Fax: 204-453-1370 Website: www.gvicds.com Company Overview / Nature of Major Business Activities: GVI Clinical Development Solutions (CDS) is an innovative contract research organization (CRO) focused on quality, timeliness and cost effective services. It is committed to excellence in clinical development services with particular experience in the cardiovascular and metabolic disease areas. CDS' flexibility and active participation in the critical stages of the clinical development process makes it an ideal partner for emerging and midsized life science companies, and academic or public health institutions carrying out their own clinical trials. Further information on CDS' clinical project management, clinical trial monitoring, clinical trial and drug safety evaluation, clinical site document management, regulatory affairs and clinical quality assurance and data management services can be found at www.gvicds.com. We consistently deliver!
Current Company Focus: The CDS provides both clinical trial consulting and hand-on clinical trial conduct service. It is looking to attract new clients and enhance its service offerings to existing clients. Regional Market Segments of Interest: Canada, United States and China Industry Market Segments of Interest: Life Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Life Sciences - Medical devices / diagnostics Life Sciences - Agricultural biotech and bioproducts Life Sciences - Functional foods and nutraceuticals Employment Opportunities: CDS is always accepting resumes and CVs for persons with previous clinical trial experience at [email protected]. Goals for BIO: CDS is interested in meeting with biotech and pharmaceutical developers in clinical development and clinical trial planning stages, medical device and diagnostics companies, and organizations who require assistance with regulatory and/or clinical planning.
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: Industrial Technology Centre (ITC) Type of Organization: Public Institution Contact Information: BIO Contact: Trevor Cornell – CEO
Mailing Address: 200-78 Innovation Drive Winnipeg, Manitoba R3C 6C2 Canada Telephone: 204-480-3333 Fax: 204-480-0345 Website: www.itc.mb.ca Company Overview / Nature of Major Business Activities: The Industrial Technology Centre (ITC) is a Special Operating Agency of Manitoba Innovation, Energy and Mines. ITC customers include industry, entrepreneurs, and government departments and agencies. ITC's provides specialized services such as: • Product Design and Analysis; • Product Testing; • Dimensional Calibration; • Data Acquisition; • Vibration/Noise Analysis; • Technical Information. • Advanced visualization and virtual reality for numerous applications (such as: medical and
surgical simulation, drug and protein modeling, 3D imaging and volume rendering, tissue modeling, and scientific visualization); as well as simulation and training for biohazardous environments.
Current Company Focus: Looking to work with clients on a contract and collaborative research basis; particularly in areas related to advanced visualization and simulation. Recent Accomplishments / Company Highlights: • Development of 3D virtual reality-based biosafety simulation and training tool. • Development of the Manitoba Visual Network, enabling remote, real-time collaboration via
high-speed networks. RegionalNorth America in General
Market Segments of Interest:
Central America in General South America in General Europe in General Asia in General Africa in General Oceana in General IndustryLife Sciences - Agricultural biotech and bioproducts
Market Segments of Interest:
Life Sciences - Industrial biotech (composites/chemicals) Life Sciences - Clean energy / environmental technologies Life Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Life Sciences - Medical devices / diagnostics Aerospace Education Mining, minerals and petroleum Agribusiness - Manufacturing & technology Clean energy and environmental industries Transportation equipment and manufacturing Building products and construction Information and communications technology Digital media, new media, film and sound Goals for BIO: • Seeking clients and collaborative partners in advanced visualization and simulation. • Specific areas of interest include:
o Biosafety Training and Simulation; o 3D Imaging and Volume Rendering; o Medical and Surgical simulation; o Drug and Protein Modeling; o Tissue Modeling and Conformal Therapy; and o Remote, Real-time Collaboration and Network Computing
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name:
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727!
Company Name Life Science Association of Manitoba (LSAM) Type of Organization: Industry Association Contact Information: BIO Contacts: Tracey Maconachie – President [email protected] Judi Bahl – Manager, Training [email protected] Stephen Szczerba – Manager, Health Industries [email protected] Mailing Address: 1000 Waverley Street Winnipeg, Manitoba R3T 0P3 Canada Telephone: 204-272-5096 Fax: 204-272-5961 Website: www.lsam.ca Company Overview / Nature of Major Business Activities: At Life Science Association of Manitoba (LSAM), it is our vision for the Life Science Industry in Manitoba to realize local and global success in innovation and commercialization. We are striving to achieve this by connecting people, information and ideas, supporting the development of Manitoba's human resource capacity through training and to strengthen the business environment for members by providing a voice for the Life Science Industry in Manitoba. LSAM represents approximately 90 organizations involved in the life science sector in Manitoba.
Current Company Focus: The Life Science Association of Manitoba builds and supports Manitoba's life sciences industries through connecting people, information and ideas, improving the business environment for our members, training and advocacy and providing a voice for the life science industry in Manitoba. Regional Market Segments of Interest: Canada United States of America Europe in General Asia in General Australia New Zealand Industry Market Segments of Interest: Life Sciences - Agricultural biotech and bioproducts Life Sciences - Functional foods and nutraceuticals Life Sciences - Industrial biotech (composites/chemicals) Life Sciences - Clean energy / environmental technologies Life Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Life Sciences - Medical devices / diagnostics Life Sciences - Aquaculture Education Agribusiness - manufacturing & technology Electricity, energy and natural gas Clean energy and environmental industries Information and communications technology Customer service Human Resources Goals for BIO: • To promote the life science sector in Manitoba; • To connect our member companies with potential partners, investors and collaborators; • To meet with our fellow industry associations in Canada and the U.S.—to ensure that we
have open lines of communication and, where possible, that we can collaborate on events and initiatives.
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: Manitoba Agri-Health Research Network Inc. (MAHRN) Type of Organization: Not-for-Profit Organization
Contact Information: BIO Contact: Lee Anne Murphy – Executive Director [email protected] Mailing Address: 13-59 Scurfield Boulevard Winnipeg, Manitoba R3Y 1V2 Canada Telephone: 204-228-3971 Website: www.mahrn.ca Company Overview / Nature of Major Business Activities: Located in Winnipeg, Manitoba, Canada, in the heart of the Canadian Prairies, the Manitoba Agri-Health Research Network (MAHRN) promotes Manitoba's capacity and capabilities for the testing and assessment of plant and animal-based bioactive compounds, from isolation and characterization through clinical proof of safety and efficacy to product development and commercialization. MAHRN is anchored by three world-class facilities: Canadian Centre for Agri-Food Research in Health and Medicine (CCARM): Strategically located within the St. Boniface General Hospital Research Centre, home to some of Canada's top researchers in cardiovascular disease and neurodegenerative disorders, CCARM is dedicated to understanding the health benefits of nutraceuticals, functional foods and natural health products. CCARM oversees world-class research
teams, made up of both agricultural and medical scientists, who explore the safety and efficacy of value-added foods and natural health products. Food Development Centre (FDC): Located 70 miles west of Winnipeg, FDC is a fee-for-service research and development organization for the agri-food industry—with expertise in product development, food engineering, regulatory affairs, nutritional labelling, and HACCP consulting. FDC has a federally licensed (Canadian Food Inspection Agency) pilot plant for processed food production that allows companies to produce and market their products nationally and internationally. Richardson Centre for Functional Foods and Nutraceuticals (RCFFN): Located in SmartPark Research and Technology Park at the University of Manitoba, the RCFFN processes, prepares, analyzes and tests new and emerging functional foods and nutraceuticals—and transfers this technology into product development, marketing and commercialization. The RCFFN's multi-disciplinary teams are focused on developing health-enhancing products from traditional prairie crops. How MAHRN Can Help: MAHRN is the primary contact point for research and industry partners seeking to access Manitoba's functional food and nutraceutical (FFN) industry. From coordinating introductions, to facilitating research, development and commercialization partnerships and activities, MAHRN assists individuals, institutions and organizations from around the world in connecting with Manitoba's research and product development capacity. Capabilities and Facilities of MAHRN Members: • Consultative services • Bioactive Discovery • Genomics, Proteomics, Metabolics • Target Screening • Biocontainment • Safety and Efficacy Assessments • Fermentation • Formulation • Preclinical Trials • Clinical Nutrition Trials • Phase I Trials • Phase II Trials • Phase III Trials • Animal Facility • Product Development- Food • Product Development-
Nutraceuticals • Pilot Plant- Food • Nutraceutical Production Suite
(tablets, capsules) • Diagnostics • Nutrition Labelling
• Packaging- Food • Packaging- Nutraceuticals
Regional Market Segments of Interest: North America in General South America in General Italy, Netherlands, United Kingdom Japan, South Korea Australia, New Zealand Industry Market Segments of Interest: Life Sciences - Agricultural biotech and bioproducts Life Sciences - Functional foods and nutraceuticals Life Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Agribusiness - food processing Agribusiness - manufacturing & technology Goals for BIO: • Raise awareness of the role of food and agriculture in the prevention and treatment of
chronic disease. • Seek and advance global collaborations with researchers, institutes and companies
engaged in the research, development and commercialization of functional foods and nutraceuticals.
• Showcase the achievements of Manitoba, with a particular focus on its leadership role in bringing agriculture and health together through food.
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name:
Medicure Inc. Type of Organization: Company Contact Information: BIO Contacts: Dr. Albert Friesen – President and CEO [email protected] Mailing Address: 2-1250 Waverley Street Winnipeg, Manitoba R3T 6C6 Canada Telephone: 1-888-435-2220 Fax: 204-488-9823 Website: www.medicure.com Company Overview / Nature of Major Business Activities: Medicure Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel small molecules to treat cardiovascular and neurological disorders. The company's primary business activity is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) in the United States for acute coronary syndromes. RegionalNorth America in General
Market Segments of Interest:
Europe in General Asia in General
Industry Market Segments of Interest: Life Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Goals for BIO: Medicure will be meeting with existing partners/collaborators at BIO 2011 and plans to identify new potential business associates and opportunities. BIO 2011 will assist Medicure in gaining perspective on the current state of the industry and emerging trends.
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: Prairie Fire Growth Ventures Inc. Type of Organization: Agriculture: Technology Development Corporation Contact Information: BIO Contacts: Harry Schulz and Erica Vido [email protected] Mailing Address: 435 Ellice Avenue
Winnipeg, Manitoba R3B 1Y6 Canada
Telephone: (204) 984-5504 Company Overview / Nature of Major Business Activities: Prairie Fire Growth Ventures is a development corporation that pursues advances for Manitoba’s agriculture sector. Our interests lie in development of advanced technologies using industry partnerships, venture capital, joint ventures, and technology transfer to create new agri-technology enterprises. Current Company Focus: Wheat related technologies Functional foods, nutraceuticals Medical technology products that have agricultural inputs Recent Accomplishments / Company Highlights: New corporation (April/2011) Industry
Market Segments of Interest: Ag-Biotech/Functional Foods/Nutraceuticals
Goals for BIO: Networking to meet prospective partners
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name:
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name:
St. Boniface General Hospital Research Centre (SBRC) Type of Organization: Not-for-Profit Organization Contact Information: BIO Contact: Dr. Bram Ramjiawan – Director of Research, Innovation and
Regulatory Affairs [email protected] Mailing Address: 351 Taché Avenue Winnipeg, Manitoba R2H 2A6 Canada Telephone: 204-235-3372 Fax: 204-235-0793 Website: www.sbrc.ca Company Overview / Nature of Major Business Activities: St. Boniface General Hospital Research Centre (SBRC) encompasses 2 free-standing medical research facilities - the G. Campbell MacLean Building and the I.H. Asper Clinical Research Institute - both operated with a combination of peer reviewed research grants, industry contracts, fund raising, and through affiliation with the University of Manitoba. SBRC is home to the Institute of Cardiovascular Sciences (ICS), Division of Neurodegenerative Disorders (DND), Canadian Centre for Agri-Food Research in Health and Medicine (CCARM), and the I.H. Asper Clinical Research Institute. Generously supported by the St. Boniface Hospital and Research Foundation, SBRC has gained a world-wide reputation for excellence. SBHRC has a close partnership with the Winnipeg Regional Health Authority's Cardiac
Sciences Program, which includes Cardiology, Cardiac Surgery, Cardiac Anaesthesia, Cardiac Critical Care & Cardiac Rehabilitation—the majority of which is based at St. Boniface Hospital campus. Our commitment is to translate discoveries into advanced technologies and new treatments. Current Company Focus: St. Boniface Hospital Research has 4 major areas of interest: • Clinical trials/regulatory affairs; • Cardiovascular research; • Neurodegenerative disorders (such as stroke and Alzheimer's Disease); and • Agri-food research. Recent Accomplishments / Company Highlights: You can read about SBRC news, awards and contracts online at: http://www.sbrc.ca/content/blogcategory/0/623/ RegionalNorth America in General
Market Segments of Interest:
Central America in General South America in General Europe in General Asia in General Africa in General Oceana in General IndustryLife Sciences - Functional foods and nutraceuticals
Market Segments of Interest:
Life Sciences – Therapeutics / pharmaceuticals / drug discovery / drug delivery Life Sciences - Medical devices / diagnostics Life Sciences - Clinical trial delivery Agribusiness – Food processing Information and communications technology Digital media, new media, film and sound Employment Opportunities: For job opportunities, please check out our website at: http://www.sbrc.ca/content/blogcategory/0/38/
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: Sphaera Technologies Inc. Type of Organization: Company Contact Information: BIO Contact: John Pacak – President & CEO [email protected] Mailing Address: 35 Mountain View Road, Box 72, Group 200, RR2 Winnipeg, Manitoba R3C 2E6 Canada Telephone: 204-633-5003 Fax: 204-633-9229 Website: www.sphaeragroup.com Company Overview / Nature of Major Business Activities: Sphaera Technologies Inc. is a biomedical engineering and development firm that specializes in complete biotechnology and medical device development solutions. RegionalNorth America in General – Mexico
Market Segments of Interest:
Central America in General South America in General Europe in General Asia in General IndustryLife Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Life Sciences - Medical devices / diagnostics
Market Segments of Interest:
Employment Opportunities: • Biomedical Engineers • Mechanical Engineers • Electrical Engineers • Software Programmers • Cell Biologists • Medical Technologists • Quality Assurance • Regulatory Affairs
Visit us at the Manitoba-Canada BIO Pavilion, in Booth 3727! Company Name: University of Manitoba – Technology Transfer Office (TTO) Type of Organization: University/College Contact Information: BIO Contact: Garold G. Breit - Executive Director [email protected]
Dr. Odd Bres - Technology Manager [email protected] Dr. Neeraj Visen – Technology Manager [email protected]
Mailing Address: 631 Drake Centre, 181 Freedman Crescent Winnipeg, Manitoba R3T 5V4 Canada Telephone: 204-474-6200 Fax: 204-261-3475 Website: http://umanitoba.ca/research/tto/ Company Overview / Nature of Major Business Activities: The University of Manitoba is the province's leading research-intensive university with 28,000 students and 3,500 faculty members. The University conducts 95% of academic research in Manitoba. The University's Technology Transfer Office (TTO) is one of Canada’s leading technology commercialization programs.
Recent Accomplishments / Company Highlights: The TTO manages 100 technology-based collaborations with the world’s leading companies including, BASF, Covidien, AB Sciex, Cangene, Lorus, YM Biosciences, Estee Lauder. These alliances cover a myriad of technologies in the Life, Physical Sciences and ICT. The TTO has launched 40 new ventures over the past two decades. These companies employ approximate 1200 across North America and produce a positive impact on the regional and Canadian economy. Today, the TTO manages an IP estate of 400 patents covering 300 platform technologies. RegionalNorth America in General
Market Segments of Interest:
Europe in General Asia in General Middle East in General IndustryLife Sciences - Agricultural biotech and bioproducts
Market Segments of Interest:
Life Sciences - Functional foods and nutraceuticals Life Sciences - Industrial biotech (composites/chemicals) Life Sciences - Clean energy / environmental technologies Life Sciences - Therapeutics / pharmaceuticals / drug discovery / drug delivery Life Sciences - Medical devices / diagnostics Life Sciences - Aquaculture Aerospace Education Agribusiness - Food processing Agribusiness - Manufacturing & technology Clean energy and environmental industries Transportation equipment and manufacturing Transportation and logistics Building products and construction Digital media, new media, film and sound